Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells

Abstract Introduction Mesenchymal stromal cells (MSCs) have opened a new window to treat inflammatory and non-inflammatory diseases. Nonetheless, their clinical applications require rigorous control and monitoring procedures to ensure full compliance with the principles of good manufacturing practic...

Full description

Bibliographic Details

Published in:	Stem Cell Research & Therapy
Main Authors:	Behnoosh Tayebi, Mahnaz Babaahmadi, Mohammad Pakzad, Mostafa Hajinasrollah, Farhad Mostafaei, Shahrbanoo Jahangiri, Amir Kamali, Hossein Baharvand, Mohamadreza Baghaban Eslaminejad, Seyedeh-Nafiseh Hassani, Ensiyeh Hajizadeh-Saffar
Format:	Article
Language:	English
Published:	BMC 2022-05-01
Subjects:	Toxicity Bone marrow Clonal mesenchymal stromal cells GMP Tumorigenicity
Online Access:	https://doi.org/10.1186/s13287-022-02899-9